Events

Recall of STA® CEPHASCREEN® 4 ml

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Diagnostica Stago.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2005-10-10
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-de-lots-du-dmdiv-sta-r-liatest-r-free-protein-s-diagnostica-stago
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    On October 06, 2005, the company Diagnostica Stago withdrew from the market the batch 042671 of the reference 00516 and the lot 042672 of the reference 00527 of the In Vitro Diagnostic Medical Device called STA® Liatest® Free Protein S following the possibility of obtaining of patient results underestimated by about 20% (relative error). This device is used for quantitative determination of free S protein by immuno-turbidimetric method on STA® line devices. has directly notified the recipients of the offending batches by means of the attached message (07/10/2005) (97 KB) validated by Afssaps. The competent European authorities concerned will be informed of this measure by Afssaps. This information is intended for laboratory managers, health facility directors and reactive vigilance correspondents for dissemination, where appropriate, to the services concerned.

Device

STA® CEPHASCREEN® 4 ml
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    Diagnostica Stago

Manufacturer

Diagnostica Stago